Reynold C. Ly

637 total citations
23 papers, 394 citations indexed

About

Reynold C. Ly is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Reynold C. Ly has authored 23 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Reynold C. Ly's work include Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Reynold C. Ly is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Reynold C. Ly collaborates with scholars based in United States, Netherlands and China. Reynold C. Ly's co-authors include Victoria M. Pratt, Michelle Whirl‐Carrillo, Ann M. Moyer, Houda Hachad, Lisa V. Kalman, Karen E. Weck, Larisa H. Cavallari, Stuart A. Scott, Andrea Gaedigk and Ron H. N. van Schaik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Reynold C. Ly

23 papers receiving 391 citations

Peers

Countries citing papers authored by Reynold C. Ly

Since Specialization

Citations

This map shows the geographic impact of Reynold C. Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reynold C. Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reynold C. Ly more than expected).

Fields of papers citing papers by Reynold C. Ly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reynold C. Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reynold C. Ly. The network helps show where Reynold C. Ly may publish in the future.

Co-authorship network of co-authors of Reynold C. Ly

This figure shows the co-authorship network connecting the top 25 collaborators of Reynold C. Ly. A scholar is included among the top collaborators of Reynold C. Ly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reynold C. Ly. Reynold C. Ly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Education of Future Pharmacogenomics Laboratory Directors 2024 ·Reynold C. Ly, Marwan K. Tayeh, Yuan Ji	1
2	DPYD Genotyping Recommendations 2024 ·Journal of Molecular Diagnostics ·Victoria M. Pratt, Larisa H. Cavallari, (unknown), Andrea Gaedigk, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, Amy Turner, Ron H. N. van Schaik, Michelle Whirl‐Carrillo, Karen E. Weck	21
3	Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), Emma M. Tillman, Amy M. Breman, Jennelle C. Hodge, (unknown), Reynold C. Ly, (unknown), (unknown), (unknown), Peter H. Schwartz, John T. Callaghan, Victoria M. Pratt, Sheryl Lynch, Michael T. Eadon, Todd C. Skaar	4
4	Cytochrome P450 Oxidoreductase ( POR ) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103 2023 ·Clinical Cancer Research ·Fei Shen, Guanglong Jiang, Santosh Philips, Laura Gardner, (unknown), (unknown), Reynold C. Ly, (unknown), Xi Wu, Chau T. Dang, Donald W. Northfelt, Todd C. Skaar, Kathy D. Miller, George W. Sledge, Bryan P. Schneider	2
5	Characterization of Reference Materials for CYP3A4 and CYP3A5 2023 ·Journal of Molecular Diagnostics ·Andrea Gaedigk, Erin C. Boone, Amy Turner, Ron H. N. van Schaik, (unknown), (unknown), Ulrich Broeckel, (unknown), Jennelle C. Hodge, Reynold C. Ly, (unknown), Matthew W. Mitchell, Ann M. Moyer, (unknown), Lisa V. Kalman	8
6	CYP3A4 and CYP3A5 Genotyping Recommendations 2023 ·Journal of Molecular Diagnostics ·Victoria M. Pratt, Larisa H. Cavallari, (unknown), Andrea Gaedigk, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, Ron H. N. van Schaik, Michelle Whirl‐Carrillo, Karen E. Weck	33
7	PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting 2023 ·Clinical Pharmacology & Therapeutics ·Amy Turner, Charity Nofziger, Bronwyn Ramey-Hartung, Reynold C. Ly, Chad Bousman, José A. G. Agúndez, Katrin Sangkuhl, Michelle Whirl‐Carrillo, Simone Vanoni, Henry M. Dunnenberger, Gualberto Ruaño, Martin A. Kennedy, (unknown), Houda Hachad, Teri E. Klein, Ann M. Moyer, Andrea Gaedigk	16
8	Computational pharmacogenotype extraction from clinical next-generation sequencing 2023 ·Frontiers in Oncology ·(unknown), Reynold C. Ly, (unknown), (unknown), (unknown), (unknown), (unknown), Jennelle C. Hodge, Amy M. Breman, Bryan P. Schneider, S. Cenk Şahinalp, Ibrahim Numanagić, Benjamin A. Salisbury, Steven M. Bray, (unknown), Todd C. Skaar	8
9	Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers 2022 ·JCO Precision Oncology ·(unknown), Reynold C. Ly, (unknown), Santosh Philips, (unknown), Milan Radovich, Marc B. Rosenman, Victoria M. Pratt, John T. Callaghan, Zeruesenay Desta, Bryan P. Schneider, Todd C. Skaar	11
10	TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase 2022 ·Journal of Molecular Diagnostics ·Victoria M. Pratt, Larisa H. Cavallari, (unknown), Andrea Gaedigk, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, Ron H. N. van Schaik, Michelle Whirl‐Carrillo, Karen E. Weck	44
11	Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report 2022 ·Frontiers in Oncology ·(unknown), (unknown), Reynold C. Ly, Costantine Albany, Milan Radovich, Bryan P. Schneider, Todd C. Skaar	12
12	Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer 2022 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), Reynold C. Ly, Santosh Philips, Marc B. Rosenman, John T. Callaghan, Milan Radovich, Brian R. Overholser, Bryan P. Schneider, James E. Tisdale, Todd C. Skaar	1
13	Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing 2022 ·Journal of Molecular Diagnostics ·Reynold C. Ly, (unknown), (unknown), (unknown), (unknown), Victoria M. Pratt, Bryan P. Schneider, Milan Radovich, Steven M. Bray, Benjamin A. Salisbury, (unknown), S. Cenk Şahinalp, Ibrahim Numanagić, Todd C. Skaar	10
14	Recommendations for Clinical CYP2D6 Genotyping Allele Selection 2021 ·Journal of Molecular Diagnostics ·Victoria M. Pratt, Larisa H. Cavallari, Andria L. Del Tredici, Andrea Gaedigk, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, Ron H. N. van Schaik, Michelle Whirl‐Carrillo, Karen E. Weck	97
15	Recommendations for Clinical Warfarin Genotyping Allele Selection 2020 ·Journal of Molecular Diagnostics ·Victoria M. Pratt, Larisa H. Cavallari, Andria L. Del Tredici, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, Michelle Whirl‐Carrillo, Karen E. Weck	45
16	Severe Capecitabine Toxicity Associated With a Rare DPYD Variant Identified Through Whole-Genome Sequencing 2020 ·JCO Precision Oncology ·Reynold C. Ly, (unknown), Patrick J. Kiel, Victoria M. Pratt, Bryan P. Schneider, Milan Radovich, Steven M. Offer, Robert B. Diasio, Todd C. Skaar	16
17	CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer 2020 ·NAR Cancer ·Junmei Cairns, Reynold C. Ly, Nifang Niu, Krishna R. Kalari, Erin E. Carlson, Liewei Wang	18
18	The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer 2019 ·SHILAP Revista de lepidopterología ·Yongxian Zhuang, Reynold C. Ly, (unknown), Jia Yu, Sisi Qin, Xiaoyang Fan, Matthew P. Goetz, Judy C. Boughey, Richard Weinshilboum, Liewei Wang	12
19	Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines 2016 ·Human Molecular Genetics ·Nifang Niu, Tongzheng Liu, Junmei Cairns, Reynold C. Ly, Xiang‐Lin Tan, Min Deng, Brooke L. Fridley, Krishna R. Kalari, Ryan Abo, Gregory D. Jenkins, Anthony Batzler, Erin E. Carlson, Poulami Barman, Sebastián Morán, Holger Heyn, Manel Esteller, Liewei Wang	16
20	Lambda Waves and Occipital Generators 2013 ·Clinical EEG and Neuroscience ·William O. Tatum, Reynold C. Ly, (unknown), Jerry J. Shih	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact